Search results for "interleukin"

showing 10 items of 1856 documents

Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected.

1992

The hypothesis of an immunological defect in schizophrenia has been supported by reports on abnormal production of interleukin-2 (IL-2) and interferons (IFNs) in schizophrenic patients. In the present study we determined the serum concentrations of IL-2, IFN-alpha and IFN-gamma in 10 first onset, neuroleptic-naive schizophrenics, in 6 pretreated patients who were drug free (1 week to 2 years) at the time of the investigation and in 15 matched healthy controls. No IFN-alpha was detected in schizophrenics' and in control sera. No differences were found in IL-2 and IFN-gamma levels between schizophrenics and controls. Thus the present study failed to support the hypothesis of an immunological …

Interleukin 2AdultMalePsychosisAlpha interferonInterferon-gammaReference ValuesInterferon αmedicineImmune ToleranceHumansInterferon gammaBiological PsychiatryInterferon alfaPsychiatric Status Rating ScalesSchizophrenia Paranoidbusiness.industryInterferon-alphaSerum concentrationmedicine.diseasePsychiatry and Mental healthSchizophreniaImmunologySchizophreniaInterleukin-2FemaleSchizophrenic Psychologybusinessmedicine.drugSchizophrenia research
researchProduct

Analysis of impaired in vitro immunoglobulin synthesis in rheumatoid arthritis.

1990

Decreased immunoglobulin production in pokeweed mitogen driven lymphocyte cultures has been reported in rheumatoid arthritis (RA). Here various activators and experimental designs have been used to determine the contribution of B cells, T cells, or monocytes to this low response. Sixty patients with RA and paired controls were studied at the onset of disease and again six months later. Concentrations of IgA, IgG, and IgM in cultures of RA peripheral blood mononuclear cells stimulated with thymus dependent activators were already decreased at the onset of the disease. Six months later RA mononuclear cells produced even lower concentrations of immunoglobulin. In contrast, stimulation with a T…

Interleukin 2AdultMalemedicine.medical_specialtyAdolescentLymphocyteT cellImmunologyImmunoglobulin ELymphocyte ActivationPeripheral blood mononuclear cellT-Lymphocytes RegulatoryGeneral Biochemistry Genetics and Molecular BiologyMonocytesArthritis RheumatoidRheumatologyInternal medicinemedicineImmunology and AllergyHumansCells CulturedAgedbiologybusiness.industryMonocytePokeweed mitogenT-Lymphocytes Helper-InducerMiddle AgedImmunoglobulin Isotypesmedicine.anatomical_structureEndocrinologyImmunologybiology.proteinInterleukin-2FemaleAntibodybusinessmedicine.drugResearch Article
researchProduct

The effect of age on mitogen responsive T cell precursors in human beings is completely restored by interleukin-2.

1992

Abstract It is well known that the function of T lymphocytes is significantly impaired by advancing age. In the present study, attempts have been made to further characterize the T cell impairment of elderly subjects. Thus, we have performed limiting dilution microculture analysis to evaluate the precursor frequency of T lymphocytes responding to a mitogenic stimulus in old and young subjects. Furthermore we have evaluated the activity of recombinant interleukin-2 (rIL-2) on these cells. The results demonstrate that in older subjects the frequency of these precursors is significantly decreased. The in vitro treatment with rIL-2 increased the frequency of mitogen responsive T lymphocyte prec…

Interleukin 2AdultMalemedicine.medical_specialtyAgingmedicine.medical_treatmentT cellT-LymphocytesIn Vitro TechniquesLymphocyte ActivationInternal medicinemedicineConcanavalin AHumansAgedAged 80 and overbiologyCell growthT lymphocyteMiddle AgedHematopoietic Stem CellsIn vitroEndocrinologyCytokinemedicine.anatomical_structureConcanavalin AAgeingImmunologybiology.proteinInterleukin-2FemaleDevelopmental Biologymedicine.drugMechanisms of ageing and development
researchProduct

Differential expression patterns of cytokines in complex regional pain syndrome.

2007

Complex regional pain syndromes (CRPS) are characterized by persistent and severe pain after trauma or surgery. Neuro-immune alterations are assumed to play a pathophysiological role. Here we set out to investigate whether patients with CRPS have altered systemic pro- and anti-inflammatory cytokine profiles compared to controls on mRNA and protein level. We studied blood cytokine mRNA and protein levels of the pro-inflammatory cytokines tumor necrosis factor-alpha (TNF), interleukin-2 (IL-2) and IL-8 and the anti-inflammatory cytokines IL-4, IL-10, and transforming growth factor-beta1 (TGF beta 1) in 40 prospectively recruited patients with CRPS I, two patients with CRPS II, and 34 controls…

Interleukin 2AdultMalemedicine.medical_specialtyNeuroimmunomodulationmedicine.medical_treatmentInternal medicinemedicineHomeostasisHumansTGF beta 1Agedbiologybusiness.industryChronic painModels ImmunologicalMiddle Agedmedicine.diseasePathophysiologyImmunity InnateAnesthesiology and Pain MedicineCytokineComplex regional pain syndromeEndocrinologyNeurologyGene Expression RegulationMcGill Pain QuestionnaireChronic Diseasebiology.proteinCytokinesTumor necrosis factor alphaFemaleNeurology (clinical)businessComplex Regional Pain Syndromesmedicine.drugPain
researchProduct

Uremic serum inhibits monocyte-dependent, but not interleukin-2-dependent steps of T cell proliferation.

1990

We examined the influence of uremic serum on antigen receptor triggered T cell proliferation in dialysis patients with impaired immune function, i.e., 12 nonresponders to hepatitis B vaccination. The dialysis patients showed a monocyte dysfunction and an increased responsiveness to interleukin 2 (IL-2) according to our previous findings. In vitro the addition of IL-2 completely reconstituted the defect. Uremic serum inhibited monocyte-dependent T cell proliferation of patients and of healthy controls. Contrary, monocyte-independent steps of T cell proliferation were not impaired by uremic serum. When IL-2 was added to cultures, the T cell proliferation in the presence of uremic serum was ev…

Interleukin 2AdultMalemedicine.medical_specialtyT cellT-LymphocytesLymphocyte ActivationMonocytesImmune toleranceImmune systemInternal medicinemedicineImmune ToleranceSuppressor Factors ImmunologicHumansAgedUremiabusiness.industryCell growthMonocyteT lymphocyteMiddle Agedmedicine.diseaseUremiamedicine.anatomical_structureEndocrinologyInterleukin-2businessmedicine.drugNephron
researchProduct

Interleukin-2 immediate type hypersensitivity?

2008

Two patients with metastatic malignant melanoma developed immediate type hypersensitivity-like symptoms while being treated with recombinant interleukin-(IL-)2 immunotherapy. Both patients showed positive skin prick tests to IL-2, enhanced basophil degranulation in vitro and responded to anti-histamines, but laboratory investigations suggested an IgE-independent, pseudoallergic mast cell degranulation against IL-2.

Interleukin 2AdultMalemedicine.medical_treatmentDermatologyImmunoglobulin EBasophil degranulationlaw.inventionlawmedicineHumansbiologybusiness.industryDegranulationImmunotherapyMiddle Agedmedicine.diseaseIn vitroImmunologybiology.proteinRecombinant DNAInterleukin-2FemaleDrug Eruptionsbusinessmedicine.drugType I hypersensitivityJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
researchProduct

Cytokine production pathway in the elderly.

1996

It is well known that aging is associated with various alterations in lymphoid cell functions, particularly with a progressive decline in immune responsiveness to exogenous antigens and increasing incidence of autoimmune phenomena. Many studies have been focused on the mechanisms of the immunologic features of aging. this review describes our results of studies performed to determine the influence of age on the capacity to produce interleukin-2 (IL-2), interferon-gamma (IFN-gamma), interleukin-4 (IL-4), interleukin-t (IL-5), interleukin-6 (IL-6) and tumor necrosis factor (TNF). Mitogen-stimulated cultures of mononuclear cells (MNC) from human beings were assessed for cytokine-producing capa…

Interleukin 2Agingmedicine.medical_treatmentT cellT-LymphocytesImmunologyBiologyIn Vitro TechniquesLymphocyte ActivationInterferon-gammaMiceImmune systemAntigenmedicineAnimalsHumansInterferon gammaLymphotoxin-alphaImmunodeficiencyAgedmedicine.diseaseCytokinemedicine.anatomical_structureImmunologyCytokinesInterleukin-2Tumor necrosis factor alphamedicine.drugImmunologic research
researchProduct

Cloned T helper cells reverting to a resting state develop increasing sensitivity in their antigen-mediated interaction with accessory cells.

1988

A cloned murine T cell line, KIII5, specific for the polypeptide poly-L(Tyr,Glu)-poly-D,L-Ala--poly-L-Lys [(T,G)-A--L] was compared at different stages after antigenic stimulation with respect to the conditions required for the reinduction of growth by varying concentrations of antigen presented on different types of accessory cells (AC). We show that the dose of antigen necessary for inducing half maximal proliferation in the presence of splenic AC shifts to considerably lower concentrations when the T cell blasts revert to a resting state (100 micrograms/ml on day 7 to 10 micrograms/ml on day 21-35). During the same time period the expression of interleukin 2 (IL2) receptor and the reacti…

Interleukin 2Antigens Differentiation T-Lymphocytemedicine.medical_specialtyT cellImmunologyAntigen presentationDose-Response Relationship ImmunologicReceptors Antigen T-CellAntigen-Presenting CellsBiologyIn Vitro TechniquesLymphocyte ActivationCell LineMiceImmune systemAntigenInternal medicinemedicineImmunology and AllergyAnimalsAntigen-presenting cellDose-Response Relationship DrugReceptors Interleukin-2T lymphocyteT-Lymphocytes Helper-InducerRecombinant ProteinsClone CellsEndocrinologymedicine.anatomical_structureInterleukin-2Clone (B-cell biology)Immunologic Memorymedicine.drugEuropean journal of immunology
researchProduct

Human interleukin 2: molecular biology, physiology and clinical possibilities.

1986

Interleukin 2Antigens Differentiation T-Lymphocytemedicine.medical_treatmentT-LymphocytesImmunologyPhysiologyGraft vs Host DiseaseCyclosporinsBiologyInterleukine 2MiceNeoplasmsmedicineImmune ToleranceImmunology and AllergyAnimalsHumansReceptors ImmunologicBone Marrow TransplantationMacrophagesLymphokineImmunization PassiveAntibodies MonoclonalImmunosuppressionReceptors Interleukin-2HematologyImmunotherapyRecombinant ProteinsKiller Cells NaturalImmunologyAntigens SurfaceInterleukin-2medicine.drugImmunobiology
researchProduct

Endothelial Nitric Oxide Synthase Regulates T Cell Receptor Signaling at the Immunological Synapse

2006

The role of nitric oxide (NO) in T cells remains controversial, and the origin and localization of endogenous NO and whether it regulates lymphocyte activation are unclear. We show here that, within minutes of binding to antigen, T cells produce NO via endothelial nitric oxide synthase (eNOS). This process required increased intracellular Ca2+ and phosphoinositide3-kinase activity. By using an eNOS-green fluorescent fusion protein and fluorescent probes to detect NO, we show that eNOS translocates with the Golgi apparatus to the immune synapse of T helper cells engaged with antigen-presenting cells (APC), where it was fully activated. Overexpression of eNOS prevented the central coalescence…

Interleukin 2CD3 ComplexNitric Oxide Synthase Type IIIT-LymphocytesImmunologyReceptors Antigen T-CellAntigen-Presenting CellsGolgi ApparatusBiologyLymphocyte ActivationNitric OxideNitric oxideImmunological synapseInterferon-gammaMicePhosphatidylinositol 3-Kinaseschemistry.chemical_compoundAntigenmedicineAnimalsHumansImmunology and AllergyCytotoxic T cellAntigensMOLIMMUNOAntigen-presenting cellNitric Oxide Synthase Type IIIMice Mutant StrainsCell biologyInfectious DiseaseschemistryInterleukin-2CalciumSignal transductionSignal Transductionmedicine.drugImmunity
researchProduct